161 related articles for article (PubMed ID: 24972773)
21. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
[TBL] [Abstract][Full Text] [Related]
22. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
[TBL] [Abstract][Full Text] [Related]
23. THE PROGNOSTIC SIGNIFICANCE OF COMBAIND EXPRESSION OF ZAP-70 AND CD38 IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Kirtava T; Vatsadze T; Azrmaiparashili E; Ghirdaladze D
Georgian Med News; 2017 Jun; (267):12-16. PubMed ID: 28726646
[TBL] [Abstract][Full Text] [Related]
24. Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
Gentile M; Cutrona G; Mosca L; Matis S; Fabris S; Lionetti M; Ilariucci F; Zupo S; Musolino C; Levato L; Molica S; Di Raimondo F; Vincelli I; Di Rienzo N; Pesce EA; Angrilli F; Federico M; Neri A; Ferrarini M; Morabito F
Am J Hematol; 2014 Jul; 89(7):743-50. PubMed ID: 24711230
[TBL] [Abstract][Full Text] [Related]
25. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
[TBL] [Abstract][Full Text] [Related]
26. Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.
Bairey O; Ruchlemer R; Rahimi-Levene N; Herishanu Y; Braester A; Berrebi A; Polliack A; Klepfish A; Shvidel L;
Ann Hematol; 2011 Oct; 90(10):1123-9. PubMed ID: 21614458
[TBL] [Abstract][Full Text] [Related]
27. The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.
Santacruz R; Villamor N; Aymerich M; Martínez-Trillos A; López C; Navarro A; Rozman M; Beà S; Royo C; Cazorla M; Colomer D; Giné E; Pinyol M; Puente XS; López-Otín C; Campo E; López-Guillermo A; Delgado J
Haematologica; 2014 May; 99(5):873-80. PubMed ID: 24700492
[TBL] [Abstract][Full Text] [Related]
28. The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience.
Molica S; Mauro FR; Callea V; Giannarelli D; Lauria F; Rotoli B; Cortelezzi A; Liso V; Foà R
Haematologica; 2010 Mar; 95(3):464-9. PubMed ID: 19903673
[TBL] [Abstract][Full Text] [Related]
29. The management of chronic lymphocytic leukemia at a single centre over a 24-year period: prognostic factors for survival.
Karmiris T; Rohatiner AZ; Love S; Carter M; Ganjoo RK; Amess J; Norton AJ; Lister TA
Hematol Oncol; 1994; 12(1):29-39. PubMed ID: 7515019
[TBL] [Abstract][Full Text] [Related]
30. Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemia.
Molica S; Vitelli G; Cutrona G; Todoerti K; Mirabelli R; Digiesi G; Morabito F; Neri A; Ferrarini M
Leuk Lymphoma; 2008 Jan; 49(1):62-7. PubMed ID: 18203013
[TBL] [Abstract][Full Text] [Related]
31. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors and risk stratification in chronic lymphocytic leukemia.
Parikh SA; Shanafelt TD
Semin Oncol; 2016 Apr; 43(2):233-40. PubMed ID: 27040701
[TBL] [Abstract][Full Text] [Related]
34. NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.
Chiaretti S; Marinelli M; Del Giudice I; Bonina S; Piciocchi A; Messina M; Vignetti M; Rossi D; Di Maio V; Mauro FR; Guarini A; Gaidano G; Foà R
Leuk Lymphoma; 2014 Dec; 55(12):2785-92. PubMed ID: 24597984
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
[TBL] [Abstract][Full Text] [Related]
36. ZAP-70 protein expression in B-cell chronic lymphoid leukemia: a single center experience from Pakistan.
Zeeshan R; Irfan SM; Sultan S; Bhimani S
Asian Pac J Cancer Prev; 2015; 16(4):1587-90. PubMed ID: 25743836
[TBL] [Abstract][Full Text] [Related]
37. Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia.
Molica S; Digiesi G; Mirabelli R; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Morabito F; Neri A; Baldini L; Ferrarini M
Eur J Haematol; 2009 Sep; 83(3):208-14. PubMed ID: 19459926
[TBL] [Abstract][Full Text] [Related]
38. Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia.
Basabaeen AA; Abdelgader EA; BaHashwan OS; Babekir EA; Abdelateif NM; Bamusa SA; Abdelrahim SO; Altayeb OA; Fadul EA; Ibrahim IK
BMC Res Notes; 2019 May; 12(1):282. PubMed ID: 31122288
[TBL] [Abstract][Full Text] [Related]
39. FcγRIIb expression in early stage chronic lymphocytic leukemia.
Bosch R; Mora A; Vicente EP; Ferrer G; Jansà S; Damle R; Gorlatov S; Rai K; Montserrat E; Nomdedeu J; Pratcorona M; Blanco L; Saavedra S; Garrido A; Esquirol A; Garcia I; Granell M; Martino R; Delgado J; Sierra J; Chiorazzi N; Moreno C
Leuk Lymphoma; 2017 Nov; 58(11):2642-2648. PubMed ID: 28372509
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic value of absolute monocyte count in chronic lymphocytic leukaemia].
Szerafin L; Jakó J; Riskó F
Orv Hetil; 2015 Apr; 156(15):592-7. PubMed ID: 25845318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
